David Maine is a solutions-driven serial entrepreneur (5x) with experience leading cross-functional teams in the development of innovative businesses based on academic research. As co-founder and CFO of biopharmaceutical company Strykagen, David has designed and implemented risk-adjusted business strategies that have achieved over $3M in funding (SBIR/STTR grants and private investment from a major biotechnology company), established private partnerships, applied IP strategy, and developed a framework for IND applications, GMP manufacturing, phase 1 clinical trials, and orphan drug designations. Mr. Maine holds a BS in Environmental Resource Economics, and an MA in Economics from the University of Nevada, Reno.